4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-016089
EVP, Chief Financial Officer sold 363 shares at $16.88 ($6,129)
- EVP, Chief Financial Officer acquired 1,049 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McClellan Michael James · EVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-03 | Exercise or conversion : show line 1 in the form | +1,049 | 12,693.27 | D | ||
| 2019-03-04 | Sale : show line 2 in the form | −363 | $16.88 | $6,129 | 12,330.27 | D |
| Open-market sales · 363 sh · avg $16.88 · $6,129 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-03 | Exercise or conversion : show line 3 in the form Restricted Share Units | −1,049 | 2,099 | D |
Loading xslF345X03/doc4.xml…